XYLD dividend yield: 9.02%. MRK dividend yield: 3.25%. XYLD sells covered calls on the S&P 500, converting equity volatility into monthly income. Yields 8-10% depending on market conditions. Similar to QYLD but with S&P 500 exposure — less volatile but comparable income mechanics. Popular for retirement income portfolios alongside other dividend ETFs. Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
XYLD sells covered calls on the S&P 500, converting equity volatility into monthly income. Yields 8-10% depending on market conditions. Similar to QYLD but with S&P 500 exposure — less volatile but comparable income mechanics. Popular for retirement income portfolios alongside other dividend ETFs.
Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
Is XYLD or MRK better for dividend income in 2026?
XYLD currently offers a 9.02% yield (3.48/share/year) while MRK offers 3.25% (3.08/share/year). XYLD provides higher current income. However, MRK has grown its dividend faster (8.2% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in XYLD vs MRK earn per year?
With $10,000 invested today: XYLD pays approximately $902/year. MRK pays approximately $325/year. With DRIP reinvestment over 10 years, these grow to $2,364/year (XYLD) and $950/year (MRK).
Does XYLD or MRK pay monthly dividends?
XYLD pays monthly dividends. MRK pays quarterly dividends. XYLD pays monthly, which is preferred by investors who need regular cash flow.
📬
Get this XYLD vs MRK comparison by email
Save your analysis + get weekly dividend insights. Free forever.